Blocking Interleukin-1 as a Novel Therapeutic Strategy for Secondary Prevention of Cardiovascular Events

Author： Abbate Antonio   Van Tassell Benjamin W.   Biondi-Zoccai Giuseppe G.L.  

Publisher： Adis International

ISSN： 1173-8804

Source： BioDrugs, Vol.26, Iss.4, 2012-08, pp. : 217-233

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Thought for food: Clinical evidence for the dietary prevention strategy in cardiovascular disease

By Lewis Barry   Sullivan David R   Watts Gerald F  

International Journal of Evidence-based Healthcare, Vol. 11, Iss. 4, 2013-12 ,pp. : 330-336

Blackwell Publishing

Access to resources Recommend Favorite

Immune Modulation as a Therapeutic Strategy for Atherosclerosis

By  

Current Drug Therapy, Vol. 5, Iss. 4, 2010-11 ,pp. : 288-300

Bentham Science Publishers

Access to resources Recommend Favorite

Garlic for the prevention of cardiovascular morbidity and mortality in hypertensive patients

By Qian Xu  

International Journal of Evidence-based Healthcare, Vol. 11, Iss. 1, 2013-03 ,pp. : 83-83

Blackwell Publishing

Access to resources Recommend Favorite

Therapeutic Potential of Oligonucleotide-Based Therapy in Cardiovascular Disease

By Morishita R.  

BioDrugs, Vol. 17, Iss. 6, 2003-01 ,pp. : 383-389

Adis International

Access to resources Recommend Favorite

Glycosylation of Therapeutic Proteins: An Effective Strategy to Optimize Efficacy

By Solá Ricardo J.   Griebenow Kai  

BioDrugs, Vol. 24, Iss. 1, 2010-02 ,pp. : 9-21

Adis International

Access to resources Recommend Favorite